Sava Infond D.O.O. Jazz Pharmaceuticals PLC Transaction History
Sava Infond D.O.O.
- $524 Billion
- Q1 2025
A detailed history of Sava Infond D.O.O. transactions in Jazz Pharmaceuticals PLC stock. As of the latest transaction made, Sava Infond D.O.O. holds 3,420 shares of JAZZ stock, worth $374,968. This represents 0.08% of its overall portfolio holdings.
Number of Shares
3,420
Previous 3,420
-0.0%
Holding current value
$374,968
Previous $421 Million
0.81%
% of portfolio
0.08%
Previous 0.07%
Shares
1 transactions
Others Institutions Holding JAZZ
# of Institutions
601Shares Held
60.5MCall Options Held
424KPut Options Held
190K-
Black Rock Inc. New York, NY6.15MShares$674 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.02MShares$660 Million0.01% of portfolio
-
Lsv Asset Management Chicago, IL2.47MShares$270 Million0.73% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.33MShares$255 Million0.07% of portfolio
-
State Street Corp Boston, MA1.97MShares$216 Million0.01% of portfolio
About Jazz Pharmaceuticals plc
- Ticker JAZZ
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,680,700
- Market Cap $6.87B
- Description
- Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...